Drug stocks retrench with broader market;
Drug stocks retrenched in early action Tuesday as the broader market slumped on disappointing retail sales figures for the month of March.
Drug stocks followed the broader market lower as investors fretted over whether Standard & Poors will lower US government's debt rating.